Workflow
Zevra Therapeutics (ZVRA) Reports Next Week: Wall Street Expects Earnings Growth

The consensus EPS estimate for the quarter has been revised 10.53% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise While the sustainability of the immediate price change and future earnings expe ...